Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance

CRISPR-Cas9 genome engineering has revolutionised high-throughput functional genomic screens. However, recent work has raised concerns regarding the performance of CRISPR-Cas9 screens using TP53 wild-type human cells due to a p53-mediated DNA damage response (DDR) limiting the efficiency of generati...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowden, Anne Ramsay, Morales-Juarez, David A, Sczaniecka-Clift, Matylda, Agudo, Maria Martin, Lukashchuk, Natalia, Thomas, John Christopher, Jackson, Stephen P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2020
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244323/
https://www.ncbi.nlm.nih.gov/pubmed/32441252
http://dx.doi.org/10.7554/eLife.55325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244323/
https://www.ncbi.nlm.nih.gov/pubmed/32441252
http://dx.doi.org/10.7554/eLife.55325

Ejemplares similares